These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28720492)

  • 41. Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease.
    Brutus L; Castillo H; Bernal C; Salas NA; Schneider D; Santalla JA; Chippaux JP
    Am J Trop Med Hyg; 2010 Nov; 83(5):1044-7. PubMed ID: 21036835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Congenital Chagas disease: an update.
    Carlier Y; Sosa-Estani S; Luquetti AO; Buekens P
    Mem Inst Oswaldo Cruz; 2015 May; 110(3):363-8. PubMed ID: 25760448
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Usefulness of PCR for monitoring benznidazole response in patients with chronic Chagas' disease: a prospective study in a non-disease-endemic country.
    Murcia L; Carrilero B; Muñoz MJ; Iborra MA; Segovia M
    J Antimicrob Chemother; 2010 Aug; 65(8):1759-64. PubMed ID: 20542903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Attenuated Trypanosoma cruzi infection in young rats nursed on infected mothers undergoing interferon-gamma treatment during pregnancy.
    Davila HO; Revelli SS; Uasuf C; Didoli G; Moreno H; Falcoff E; Bottasso OA
    Immunopharmacology; 1997 Aug; 37(1):1-6. PubMed ID: 9285238
    [No Abstract]   [Full Text] [Related]  

  • 45. Vertical transmission of Trypanosoma cruzi in the Province of Choapa, IV Region, Chile: Preliminary Report (2005-2008).
    Apt W; Zulantay I; Solari A; Ortiz S; Oddo D; Corral G; Truyens C; Carlier Y
    Biol Res; 2010; 43(3):269-74. PubMed ID: 21249297
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: a Pilot Short-Term Follow-Up Study with Adult Patients.
    Álvarez MG; Hernández Y; Bertocchi G; Fernández M; Lococo B; Ramírez JC; Cura C; Albizu CL; Schijman A; Abril M; Sosa-Estani S; Viotti R
    Antimicrob Agents Chemother; 2016 Feb; 60(2):833-7. PubMed ID: 26596935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The innate immune response status correlates with a divergent clinical course in congenital Chagas disease of twins born in a non-endemic country.
    Fernández-Villegas A; Thomas MC; Carrilero B; Téllez C; Marañón C; Murcia L; Moralo S; Alonso C; Segovia M; López MC
    Acta Trop; 2014 Dec; 140():84-90. PubMed ID: 25149352
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of Patients for Whom Benznidazole Was Released Through the CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease - United States, 2011-2018.
    Herwaldt BL; Dougherty CP; Allen CK; Jolly JP; Brown MN; Yu P; Yu Y
    MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(29):803-805. PubMed ID: 30048425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgG Subclasses and Congenital Transmission of Chagas Disease.
    Roca C; Málaga-Machaca ES; Verastegui MR; Scola B; Valencia-Ayala E; Menduiña MDC; Noazin S; Bowman NM; Tinajeros F; Gilman RH;
    Am J Trop Med Hyg; 2021 Sep; 105(5):1187-1192. PubMed ID: 34491223
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation and Management of Congenital Chagas Disease in the United States.
    Edwards MS; Stimpert KK; Bialek SR; Montgomery SP
    J Pediatric Infect Dis Soc; 2019 Nov; 8(5):461-469. PubMed ID: 31016324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benznidazole for the treatment of Chagas disease.
    Losada Galván I; Alonso-Padilla J; Cortés-Serra N; Alonso-Vega C; Gascón J; Pinazo MJ
    Expert Rev Anti Infect Ther; 2021 May; 19(5):547-556. PubMed ID: 33043726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Higher congenital transmission rate of Trypanosoma cruzi associated with family history of congenital transmission.
    Danesi E; Fabbro DL; Segura EL; Sosa-Estani S
    Rev Soc Bras Med Trop; 2020; 53():e20190560. PubMed ID: 32348431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of benznidazole treatment on the functional response of Trypanosoma cruzi antigen-specific CD4+CD8+ T cells in chronic Chagas disease patients.
    Pérez-Antón E; Egui A; Thomas MC; Puerta CJ; González JM; Cuéllar A; Segovia M; López MC
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006480. PubMed ID: 29750791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.
    Viotti R; Vigliano C; Lococo B; Alvarez MG; Petti M; Bertocchi G; Armenti A
    Expert Rev Anti Infect Ther; 2009 Mar; 7(2):157-63. PubMed ID: 19254164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community].
    Paricio-Talayero JM; Benlloch-Muncharaz MJ; Collar-del-Castillo JI; Rubio-Soriano A; Serrat-Pérez C; Magraner-Egea J; Landa-Rivera L; Sánchez-Palomares M; Beseler-Soto B; Santos-Serrano L; Ferriol-Camacho M; Mut-Buigues J; Tomás-Vila M; del Carmen Alonso-Jiménez M; Domínguez-Márquez V; Igual-Adell R
    Enferm Infecc Microbiol Clin; 2008 Dec; 26(10):609-13. PubMed ID: 19100190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Congenital infection by Trypanosoma cruzi in an endemic area of Chile: a multidisciplinary study.
    Apt W; Zulantay I; Arnello M; Oddó D; González S; Rodríguez J; Kemmerling U; Truyens C; Carlier Y
    Trans R Soc Trop Med Hyg; 2013 Feb; 107(2):98-104. PubMed ID: 23222947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas' disease.
    Sperandio da Silva GM; Mediano MFF; Hasslocher-Moreno AM; Holanda MT; Silvestre de Sousa A; Sangenis LHC; Brasil PEAAD; Mejía RA; Fux CP; Cubides JC; Saraiva RM; Brum-Soares LM
    J Antimicrob Chemother; 2017 Sep; 72(9):2596-2601. PubMed ID: 28645201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Trypanosoma cruzi seroprevalence in pregnant women and screening by PCR and microhaematocrit in newborns from Guanajuato, Mexico.
    Montes-Rincón LM; Galaviz-Silva L; González-Bravo FE; Molina-Garza ZJ
    Acta Trop; 2016 Dec; 164():100-106. PubMed ID: 27596439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Maternal factors associated to congenital transmission of Chagas disease in children born and siblings in Chaco province, Argentina.].
    Chaparro RM; Genero S
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):279-287. PubMed ID: 30734707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic Chagas disease with advanced cardiac complications in Japan: Case report and literature review.
    Imai K; Maeda T; Sayama Y; Osa M; Mikita K; Kurane I; Miyahira Y; Kawana A; Miura S
    Parasitol Int; 2015 Oct; 64(5):240-2. PubMed ID: 25744336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.